Delivery Order SPE2DB20D7059-SPE2DB25FQAN4

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $8.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,305.16, is a Firm Fixed Price Delivery Order for the provision of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract has an ultimate completion date of November 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,910.00 Firm Fixed Price Delivery Order is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, to support federal healthcare programs. The contract has a performance period through July 26, 2024 and was not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,773.68 firm fixed-price delivery order is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through February 5, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to AmerisourceBergen Drug Corp (a major pharmaceutical distributor) is a delivery order valued at $1,251.76 for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of August 30, 2024 and is a firm-fixed price arrangement. AmerisourceBergen holds a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, worth $7,616.70, is a delivery order for the supply of SYNVISC-ONE SYRINGE 6ML pharmaceutical products. The contract has a firm fixed-price pricing type and an ultimate completion date of September 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of essential medical commodities to...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,252.48, is for the delivery of SYNVISC-ONE SYRINGE 6ML, a medical product used in healthcare programs. The contract has an ultimate completion date of October 16, 2023 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is a delivery order valued at $28,319.43 awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract covers the procurement of SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through July 29, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award, with ID SPE2DB20D1004|SPE2DB25FNETA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SYNVISC-ONE SYRINGE 6ML, a medical product, with a ceiling value of $3,984.52 and a completion date of February 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $198,634.53, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award is an order placed against an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $3,785.77, is for the procurement of SYNVISC-ONE SYRINGE 6ML, a medical product used in healthcare. This order is part of Amerisourcebergen's $999,999,999 IDC with the DLA, which serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQAN4
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,462.74, is a Firm Fixed Price Delivery Order for the medical product "SYNVISC-ONE SYRINGE 6ML". The contract has an ultimate completion date of February 25, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award was not designated with a set-aside requirement, indicating open competition.

Generated 6/1/25, 3:35 AM